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Available online 14 March 2016AbstractObjectives: Type 2 diabetes mellitus (T2DM) increases fracture risk despite normal to high levels of bone mineral density. Bone quality is known
to affect bone fragility in T2DM. The aim of this study was to clarify the trabecular bone microstructure and cortical bone geometry of the femur
in T2DM model rats.
Methods: Five-week-old Otsuka Long-Evans Tokushima Fatty (OLETF; n ¼ 5) and Long-Evans Tokushima Otsuka (LETO; n ¼ 5) rats were
used. At the age of 18 months, femurs were scanned with micro-computed tomography, and trabecular bone microstructure and cortical bone
geometry were analyzed.
Results: Trabecular bone microstructure and cortical bone geometry deteriorated in the femur in OLETF rats. Compared with in LETO rats, in
OLETF rats, bone volume fraction, trabecular number and connectivity density decreased, and trabecular space significantly increased.
Moreover, in OLETF rats, cortical bone volume and section area decreased, and medullary volume significantly increased.
Conclusions: Long-term T2DM leaded to deterioration in trabecular and cortical bone structure. Therefore, OLETF rats may serve as a useful
animal model for investigating the relationship between T2DM and bone quality.
© 2016 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Type 2 diabetes mellitus (T2DM) increases the risk of frac-
ture despite normal to high levels of bone mineral density
(BMD) [1e3]. Vestergaard reported a 1.4-fold increase in hip
fracture risk in patients with T2DM, as compared with in
healthy people without T2DM, though BMD Z-score of the
spine and hip in T2DM patients was high [4]. Thus, it seems
likely that bone fragility in T2DM is affected by bone quality
rather than bone mass. Bone quality, that reflects bone strength,* Corresponding author.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).encompasses bone architecture, turnover, damage accumula-
tion and mineralization [5]. Low bone turnover in T2DM was
evident by decreased bone formation/resorption markers,
though both the markers were reported to increase in several
studies [1e3,6,7]. Moreover, T2DM was associated with
decreased total bone area, decreased trabecular bone score
(TBS) [2,6,8], decreased cortical bone area and increased
cortical porosity [2,3,6,9]. Accumulation of advanced glycation
end products impaired enzymatic cross-links and resulted in
excessive formation of non-enzymatic cross-links, leading to a
decline in bone properties and detrimental effects on bone cells
[1e3,6,10]. Patients with inadequately controlled T2DM
showed about 1.5-fold increase in fracture risk despite having a
higher BMD, as compared with healthy people withoutElsevier B.V. This is an open access article under the CC BY-NC-ND license
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difference in fracture risk between T2DM patients and healthy
people [11]. Low trabecular bone score was associated with
worse glycemic control in T2DM [8], suggesting that hyper-
glycemia may affect factors that influence bone metabolism.
However, there has been no consensus regarding the effects of
T2DM on bone metabolism and properties as yet.
Animal models were widely used to examine not only
T2DM pathophysiology but also the effects of T2DM on bone
quality factors. Since each DM model strain had unique
characteristics, the most appropriate DM model was chosen
for the study's purpose [12]. Otsuka Long-Evans Tokushima
Fatty (OLETF) rats displayed the clinical and pathological
features of human non-insulin-dependent diabetes mellitus
(NIDDM), as well as the characteristics of late-onset hyper-
glycemia, chronic DM, mild obesity, male inheritance, hy-
perplastic foci of pancreatic islets and renal complications
[13]. Omi et al. investigated bone metabolism in OLETF
rats, and found that OLETF rats can serve as a useful model
for NIDDM with osteopenia [14]. However, they did not
investigate trabecular bone microstructure (TBM) or cortical
bone geometry (CBG). Only a few studies have reported bone-
related parameters in OLETF rats so far, though bone structure
has been investigated in other rat strain models [15e22]. Thus,
TBM and CBG remained unclear in OLETF rats, of which
symptoms were similar to those of human T2DM.
The aims of this study were to clarify TBM and CBG in
OLETF rats in order to gain further insight on bones in long-
term T2DM patients and also to examine whether OLETF rats
can serve as a useful animal model for investigating the
relationship between T2DM and bone quality.
2. Methods2.1. AnimalsThis study was performed in accordance with the Animal
Experimentation Guidelines set forth by the Committee for
Research Facilities of Laboratory Animal Science at Kio
University. Five-week-old male OLETF (n ¼ 5) rats were used
as a model for T2DM, and LETO (n ¼ 5) rats were used as
controls (Japan SLC Inc., Hamamatsu, Japan). All rats were
housed in cages at 23 ± 2 C under a 12-h dayenight cycle for
17 months. They were fed a standard rat chow (CE-2; CLEA
Japan Inc., Tokyo, Japan) and water ad libitum throughout the
experiment. At the age of 18 months, femurs were harvested
from all rats under anesthesia.
At the point of analysis (at the age of 18 months), the onset of
T2DM in OLETF rats was demonstrated by increased levels of
blood glucose concentration (229.3 ± 104.5 mg/dL) and of
HbA1c (8.3± 1.3%), as comparedwith those ofLETO rats (blood
glucose concentration, 70.8 ± 11.5 mg/dL; HbA1c, 5.0 ± 0.1%).2.2. Bone structure analysisLeft femurs were dissected out, and soft tissues were
removed. Using an X-ray micro-computed tomography(micro-CT; Hitachi Medical Corp., Tokyo, Japan), distal fe-
murs were scanned at 65 kV, 90 mA, and with a voxel size of
21.3 mm, in the high-definition mode for analysis of TBM. The
region of interest (ROI) for TBM was a 2 mm-length portion
of the metaphysis, and therefore the first slice was scanned
1 mm distal from the physeal-metaphyseal demarcation.
Likewise, the central portion of femurs were simultaneously
scanned by micro-CT at 65 kV, 90 mA, and with a voxel size of
18.1 mm using the high-definition mode for analysis of CBG.
The ROI for CBG was a 2 mm-length portion distal from the
center of the femur. Scanned data were transmitted to a per-
sonal computer, in which TBM and CBG of the ROI were
analyzed using the bone analysis software (TRI BON 3D,
RATOC System Engineering Co. Ltd., Tokyo, Japan). Indi-
vidual TBM and CBG parameters were obtained by analyzing
104 slice data from one ROI per animal.
Parameters of TBM were tissue volume (TV), bone volume
(BV), bone volume fraction (BV/TV), trabecular thickness
(Tb.Th), trabecular number (Tb.N), trabecular separation
(Tb.Sp), connectivity density (Conn.D), trabecular bone
pattern factor (TBPf), structure model index (SMI) and degree
of anisotropy (DOA). Parameters of CBG were cortical bone
volume (CV), all bone volume (AV), medullary volume (MV),
cortical bone ratio (CV/AV), cortical bone thickness (Ct) and
cortical bone section area (CSa).2.3. Statistical data analysisAll values are expressed as mean ± standard deviation.
Differences between OLETF and LETO rats were examined
with the ManneWhitney U test. All statistical analyses were
performed using the Excel Statistics software (Excel 2012
version 1.15 for Windows; Social Survey Research Informa-
tion Co. Ltd., Tokyo, Japan). P < 0.05 was considered sta-
tistically significant.
3. Results3.1. Body weight and femur lengthThere was no significant difference in final body weight
between LETO rats (575.7 ± 18.3 g) and OLETF rats
(496.1 ± 87.6 g). However, femur length was significantly
shorter in OLETF rats (39.4 ± 1.2 mm) than in LETO rats
(41.8 ± 0.3 mm).3.2. TBM and CBG parametersOLETF rats at the age of 18 months showed the deterio-
ration in TBM and CBG parameters compared with LETO rats
at the same age (Table 1). In TBM parameters, BV, BV/TV,
Tb.N and Conn.D were significantly lower, and Tb.Th, Tb.Sp,
TBPf and SMI were significantly higher, in OLETF rats than
in LETO rats. With respect to CBG parameters, CV, CV/AV
and CSa were significantly lower in OLETF rats than in LETO
rats. To the contrary, MV was significantly higher in OLETF
rats than in LETO rats (Table 1).
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tions of the ROI in OLETF rats and LETO rats. Connectivity
of trabecular bone at the femoral metaphysis appears to be
well maintained in LETO rats, whereas trabecular bone in
OLETF rats is diminished and disconnected. Thus, deteriora-
tion of trabecular bones at the distal femoral metaphysis is
evident in OLETF rats. On the other hand, the cross sections of
cortical bones at the femoral diaphysis shows that the internal
cortical bone of the femoral shaft is resorbed and thereby bone
marrow area is increased in OLETF rats, as compared with in
LETO rats.
4. Discussion
Dhaliwal et al. found that TBS is lower in women with
T2DM or in women under worse glycemic control
(HbA1c > 7.5%) than in women without T2DM [8]. Moreover,
the lumbar spine TBS has been reported to predict osteopo-
rotic fractures in DM [23]. Pritchard et al. showed that women
with T2DM have larger holes in the trabecular bone network
of the radius compared to women without T2DM [24]. How-
ever, some studies showed no significant difference in TBM
between women with T2DM and those without T2DM
[25e27], though the augmented cortical porosity was often
reported in women with T2DM [6,9,27,28].
Animal T2DM models showed deterioration in both
trabecular and cortical bone structure [15e22]. Body weight
decreased after onset of DM in these models [15e22], and
bone length of the lower limbs was shorter [16,17,19,21]. In
contrast to humans, BMD in the lower limbs of T2DM ratsTable 1
Trabecular bone microstructure and cortical bone geometry parameters
LETO rats OLETF rats
Trabecular bone microstructure parameters
TV (mm3) 13.3 ± 0.3 13.3 ± 1.2
BV (mm3) 1.80 ± 0.13 0.40 ± 0.14*
BV/TV (%) 13.5 ± 1.0 3.0 ± 1.1*
Tb.Th (mm) 93.7 ± 0.6 107.8 ± 13.4*
Tb.N (1/mm) 1.11 ± 0.08 0.24 ± 0.12*
Tb.Sp (mm) 283.8 ± 8.1 721.7 ± 277.6*
Conn.D (1/mm) 14.3 ± 1.8 1.3 ± 0.8*
TBPf 9.6 ± 0.6 13.7 ± 3.0*
SMI 2.2 ± 0.1 3.0 ± 0.3*
DOA 1.7 ± 0.1 1.8 ± 0.1
Cortical bone geometry parameters
CV (mm3) 13.5 ± 0.4 11.6 ± 1.4*
MV (mm3) 7.2 ± 0.5 11.7 ± 1.3*
CV/all bone volume (%) 65.2 ± 1.9 49.8 ± 0.6*
Ct (mm) 370.5 ± 61.0 440.7 ± 33.1
CSa (mm2) 6.6 ± 0.2 5.7 ± 0.7*
Values are expressed as mean ± SD of 5 animals. *Significantly different from
LETO rat values (p < 0.05).
BV, bone volume; BV/TV, bone volume fraction; Conn.D, connectivity den-
sity; CSa, cortical bone section area; Ct, cortical bone thickness; CV, cortical
bone volume; DOA, degree of anisotropy; MV, medullary volume; SMI,
structure model index; TBPf, trabecular bone pattern factor; Tb.N, trabecular
number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness; TV, tissue
volume.was within the range from low to normal values, compared
with that of control rats [15e22]. Shorter femur was shown in
this study as reported in the previous studies using T2DM
model rats [16,17,19,21]. Lapmanee et al. fed 5-week-old
Goto-Kakizaki (GK) rats with normal diet for 11 weeks, and
thereafter found that differentiation and turnover of the growth
plate chondrocytes are impaired in these GK rats [17]. They
also observed that chondrocyte precursors are arrested and
retained in the resting zone, and consequently a decrease in the
number of matured chondrocytes in the hypertrophic zone
causes deceleration in both endochondral bone growth and
bone elongation in the GK rats [17]. Kimura et al. showed that
in spontaneously diabetic Torii (SDT) efa/fa rats at the age of
40 weeks, hyperglycemia- and obesity-induced deterioration
of bone formation involves severe bone loss, shortening in
bone length, deterioration in bone geometrical properties and
decrease in bone strength [19]. Thus, hyperglycemia in T2DM
affected not only bone properties but also bone growth and
consequently weakened bone strength [16,19]. Therefore, it
seems likely that in OLETF rats, as well as in the above-
mentioned other T2DM rats, bone growth/elongation is sup-
pressed by hyperglycemia.
In trabecular bone of T2DM rats, BV/TV and Tb.Th values
were smaller, though Tb.N and Tb.Sp remained unchanged
[16,17,19,20]. On the other hand, in the present study, OLETF
rats exhibited the increase in Tb.Th and Tb.Sp and the
decrease in BV/TV, Tb.N and Conn.D. In addition to such
TBM deterioration, the increase in TBPf and SMI showed that
trabecular bone of OLETF rats is essentially shaped like rod.
BMD was higher in OLETF rats than in control LETO rats
until age 40 weeks [14]. The BMD and trabecular bone con-
ditions observed in OLETF rats were similar to those in
humans [2,6,8]. In histomorphological studies, osteoblast
surface normalized by bone surface, osteoid thickness,
mineralizing surface, bone formation rate and mineral appo-
sition rate were reduced in T2DM model rats [16e18].
However, osteoclast surface and eroded surface varied among
these studies [16e18]. Such differences may be attributed to
difference in animal models or the rat ages, which are closely
related to the timing of DM symptom onset. Serum osteocalcin
and parathyroid hormone levels have been reported to range
between low and normal values in T2DM rats
[14,16,18,19,22,29], though bone resorption markers and bone
resorption activities varied among the studies
[14,16,19,22,29]. Thus, bone formation was evidently
decreased in T2DM model rats like OLETF rats. Therefore,
deterioration of TBM in our OLETF rats would have been
caused by impaired bone formation, that is partially due to
reduced mineralization and malfunction of osteoblasts.
BMD of lower limbs were lower in T2DM rats than in
control rats [19,21,22]. For instance, in OLETF rats, although
femoral BMD was higher at age 33 weeks, BMD of the tibia
diaphysis was decreased after age 56 weeks [14]. Several
studies showed low to normal values for cross-sectional area
or cortical thickness and normal to high values for cortical
periosteal perimeters [16,17,19,21,22], though the cortical
endosteal perimeter remained unchanged [15,17,21]. In T2DM
Fig. 1. Representative cross sections of region of interest in femoral metaphysis trabecular bone and diaphysis cortical bone. Cross section A and B show
metaphysis trabecular bone of LETO rats and of OLETF rats, respectively. Cross section C and D show diaphysis cortical bone of LETO rats and of OLETF rats,
respectively. Bar ¼ 1 mm.
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dent on both bone size and bone properties including BMD.
Sixteen-week-old GK rats showed lower mineralization sur-
face, lower bone formation rate, lower CSa and shorter tibial
length, but normal Ct value, in tibia, as compared with age-
matched control rats [17]. Moreover, 6-month-old GK rats
showed lower mineralization surface, lower bone formation
rate and shorter femoral length, but normal Ct and CSa values,
in femur, as compared with control rats [16]. In addition, SDT-
fa/fa rats showed lower urine deoxypyridinoline at the age of 8
weeks, and also lower Ct of femur and lower serum osteo-
calcin at the age of 8, 16 and 40 weeks, compared with control
rats [19]. Nine-week-old ZDF-fa/fa rats also showed lower Ct
of femur, lower serum osteocalcin and lower serum carboxy-
terminal collagen crosslinks, compared with control rats
[22]. In the present study, OLETF rats showed increased MV,
decreased CV and decreased CSa. In fact, the cortical endos-
teal area was obviously resorbed (Fig. 1). Thus, the deterio-
ration of CBG was observed in the present OLETF rats as
reported in other rat DM models [16,17,19e22]. In view of the
above-mentioned facts, such deterioration of CBG, as well as
of TBA, would have been caused by impaired bone formation
that is partially due to lowered mineralization, impaired dif-
ferentiation/turnover of growth plate chondrocytes and mal-
function of osteoblasts, resulting in small size of bones in our
OLETF rats.
Our findings reported herein suggest that long-term DM
(age 18 months) leads to the deterioration of both TBM and
CBG due to impaired bone formation [29]. T2DM also may
affect calcium metabolism. In addition to low serum osteo-
calcin levels [29], high sclerostin [29] and low vitamin D
[14] levels have been reported in OLETF rats. The greater
deterioration of TBM and CBG in this study may reflect the
chronic DM condition (i.e., DM for long-term period over 1
year). In conclusion, OLETF rats may serve as a useful
animal model for investigating the relationship between
T2DM and bone quality or bone metabolism. Therefore,
OLETF rats may be used to explore a potent rehabilitation
modality for preventing or treating bone fragility in chronic
DM patients.
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